These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2990772)

  • 41. Natriuretic effect of acute nifedipine administration is not mediated by the renal kallikrein-kinin system.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Bandiera F; Manunta P; Rubattu S; Troffa C; Tonolo GC
    J Cardiovasc Pharmacol; 1987 May; 9(5):536-40. PubMed ID: 2439833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endogenous natriuretic factors. 2: Characterization of natriuretic and vasopressive substances from human uremic urine.
    Levine BH; Murray ED; Bigornia AE; DeWind SA; Wechter WJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S63-8. PubMed ID: 7508032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Intern Med; 1994 Dec; 236(6):665-74. PubMed ID: 7989902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Total and kallikrein arginine esterase activities in the urine of salt-hypertensive susceptible and resistant rats.
    Sustarsic DL; McPartland RP; Rapp JP
    Hypertension; 1980; 2(6):813-20. PubMed ID: 7007238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. George E. Brown memorial lecture. Role of atrial peptides in body fluid homeostasis.
    Ballermann BJ; Brenner BM
    Circ Res; 1986 May; 58(5):619-30. PubMed ID: 3011307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urinary excretion of prostaglandin E like material and kallikrein: effects of furosemide.
    Halushka PV; Margolius HS; Allen H; Conradi EC
    Prostaglandins; 1979 Sep; 18(3):359-68. PubMed ID: 260996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxytocin-induced natriuresis mediated by the renal kallikrein-kinin system in anesthetized male rats.
    Adachi K; Majima M; Katori M; Nishijima M
    Jpn J Pharmacol; 1995 Mar; 67(3):243-52. PubMed ID: 7630042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atrial natriuretic factor influences renal diurnal rhythm in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    Hypertension; 1992 Jul; 20(1):80-4. PubMed ID: 1535613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new endogenous natriuretic factor: LLU-alpha.
    Wechter WJ; Kantoci D; Murray ED; D'Amico DC; Jung ME; Wang WH
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6002-7. PubMed ID: 8650209
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of atrial natriuretic peptide (ANP) on the renal kallikrein-kinin system in normotensive and spontaneously hypertensive rats].
    Bönner G; Hirzel B; Ganten D; Kaufmann W
    Z Kardiol; 1988; 77 Suppl 2():85-91. PubMed ID: 2841816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vasoactive humoral systems and sodium transport in erythrocytes of normotensive offsprings of essential hypertensive subjects.
    Janata V; Bultasová H; Pinsker P
    Physiol Bohemoslov; 1990; 39(1):65-70. PubMed ID: 2142790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of salt sensitivity on the blood pressure response to exogenous kallikrein in essential hypertensive patients.
    Bellini C; Ferri C; Piccoli A; Carlomagno A; Di Francesco L; Bonavita MS; Santucci A; Balsano F
    Nephron; 1993; 65(1):28-35. PubMed ID: 8413787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of renal kallikrein in modulating the antihypertensive effect of a single oral dose of captopril in normal- and low-renin essential hypertensives.
    Madeddu P; Oppes M; Rubattu S; Dessi'-Fulgheri P; Glorioso N; Soro A; Rappelli A
    J Hypertens; 1987 Dec; 5(6):645-8. PubMed ID: 3323316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased prostaglandin E2 excretion with oral kallikrein treatment in hypertensive and normotensive subjects.
    Muller HM; Overlack A; Stumpe KO; Kollock R; Ressel C
    Adv Exp Med Biol; 1983; 156 (Pt B)():1005-9. PubMed ID: 6574693
    [No Abstract]   [Full Text] [Related]  

  • 55. Atrial natriuretic factor has a direct, prostaglandin-independent action on kidneys.
    Keeler R
    Can J Physiol Pharmacol; 1982 Aug; 60(8):1078-82. PubMed ID: 6889909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility.
    Kleinert HD; Maack T; Atlas SA; Januszewicz A; Sealey JE; Laragh JH
    Hypertension; 1984; 6(2 Pt 2):I143-7. PubMed ID: 6539299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impaired renal kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension.
    Stumpe KO; Overlack A; Ressel C; Krück F
    Agents Actions; 1980 Sep; 10(4):349-52. PubMed ID: 6905641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Manunta F; Rubatti S; Rappelli A
    Agents Actions Suppl; 1987; 22():373-80. PubMed ID: 2449054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats.
    Ideishi M; Miura S; Sakai T; Sasaguri M; Misumi Y; Arakawa K
    J Hypertens; 1994 Jun; 12(6):653-61. PubMed ID: 7963490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Observations on a low molecular weight natriuretic and Na-K-ATPase inhibitory material in urine.
    Clarkson EM; de Wardener HE
    Clin Exp Hypertens A; 1985; 7(5-6):673-83. PubMed ID: 2990768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.